Acute priapism associated with the use of sildenafil in a patient with sickle cell trait.
Kassim
A A
AA
Fabry
M E
ME
Nagel
R L
RL
D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000328:Adult; D006152:Cyclic GMP / Q000378:metabolism; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; D006801:Humans; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D010413:Penis / Q000098:blood supply / Q000187:drug effects / Q000201:enzymology; D010726:Phosphodiesterase Inhibitors / Q000009:adverse effects*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010879:Piperazines / Q000009:adverse effects*; D011317:Priapism / Q000139:chemically induced* / Q000209:etiology; D011687:Purines; D012805:Sickle Cell Trait / Q000150:complications*; D000068677:Sildenafil Citrate; D013450:Sulfones
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate; D010727:Phosphoric Diester Hydrolases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D054706:Cyclic Nucleotide Phosphodiesterases, Type 5; C517381:PDE5A protein, human; D006152:Cyclic GMP